Form 4 Filing for Alaunos Therapeutics, Inc.

Michael Allen Jerman, a director at Alaunos Therapeutics, Inc., acquired 6,032 shares of common stock on April 29, 2026. These shares were issued in lieu of board fees. The acquisition price was $2.59 per share, resulting in a post-transaction ownership of 15,621 shares. The transaction code indicates acquisition, and the ownership is direct.